235 related articles for article (PubMed ID: 8927052)
1. In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.
Khandelwal RL; Pugazhenthi S
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):87-94. PubMed ID: 8927052
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice.
Pugazhenthi S; Angel JF; Khandelwal RL
Metabolism; 1991 Sep; 40(9):941-6. PubMed ID: 1910143
[TBL] [Abstract][Full Text] [Related]
3. Effects of high sucrose diet on insulin-like effects of vanadate in diabetic rats.
Pugazhenthi S; Angel JF; Khandelwal RL
Mol Cell Biochem; 1993 May; 122(1):77-84. PubMed ID: 8350867
[TBL] [Abstract][Full Text] [Related]
4. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
Blondel O; Simon J; Chevalier B; Portha B
Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like effect of vanadate on malic enzyme and glucose-6-phosphate dehydrogenase activities in streptozotocin-induced diabetic rat liver.
Pugazhenthi S; Khandelwal RL; Angel JF
Biochim Biophys Acta; 1991 Jun; 1083(3):310-2. PubMed ID: 2049397
[TBL] [Abstract][Full Text] [Related]
6. Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats.
Pugazhenthi S; Khandelwal RL
Diabetes; 1990 Jul; 39(7):821-7. PubMed ID: 2113014
[TBL] [Abstract][Full Text] [Related]
7. Does the insulin-mimetic action of vanadate involve insulin receptor kinase?
Pugazhenthi S; Khandelwal RL
Mol Cell Biochem; 1993 Nov; 127-128():211-8. PubMed ID: 7523848
[TBL] [Abstract][Full Text] [Related]
8. Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat.
Pugazhenthi S; Hussain A; Yu B; Brownsey RW; Angel JF; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):211-5. PubMed ID: 8927041
[TBL] [Abstract][Full Text] [Related]
9. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Rossetti L; Lauglin MR
J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
[TBL] [Abstract][Full Text] [Related]
10. Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats.
Pugazhenthi S; Angel JF; Khandelwal RL
Mol Cell Biochem; 1993 May; 122(1):69-75. PubMed ID: 8350866
[TBL] [Abstract][Full Text] [Related]
11. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate.
Gupta D; Raju J; Prakash J; Baquer NZ
Diabetes Res Clin Pract; 1999 Oct; 46(1):1-7. PubMed ID: 10580609
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate.
Brichard SM; Ongemba LN; Girard J; Henquin JC
Diabetologia; 1994 Nov; 37(11):1065-72. PubMed ID: 7867878
[TBL] [Abstract][Full Text] [Related]
13. Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism.
Sun Q; Sekar N; Goldwaser I; Gershonov E; Fridkin M; Shechter Y
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E403-10. PubMed ID: 10913041
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats.
Berg EA; Wu JY; Campbell L; Kagey M; Stapleton SR
Biochimie; 1995; 77(12):919-24. PubMed ID: 8834772
[TBL] [Abstract][Full Text] [Related]
15. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.
Brichard SM; Okitolonda W; Henquin JC
Endocrinology; 1988 Oct; 123(4):2048-53. PubMed ID: 3046930
[TBL] [Abstract][Full Text] [Related]
16. Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):125-9. PubMed ID: 8927027
[TBL] [Abstract][Full Text] [Related]
17. Gluconeogenesis in non-obese diabetic (NOD) mice: in vivo effects of vandadate treatment on hepatic glucose-6-phoshatase and phosphoenolpyruvate carboxykinase.
Mosseri R; Waner T; Shefi M; Shafrir E; Meyerovitch J
Metabolism; 2000 Mar; 49(3):321-5. PubMed ID: 10726908
[TBL] [Abstract][Full Text] [Related]
18. Control of glycogen synthase and phosphorylase in hepatocytes from diabetic rats. Effects of glucagon, vasopressin, and vanadate.
Rodríguez-Gil JE; Gómez-Foix AM; Ariño J; Guinovart JJ; Bosch F
Diabetes; 1989 Jun; 38(6):793-8. PubMed ID: 2498142
[TBL] [Abstract][Full Text] [Related]
19. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression.
Brichard SM; Assimacopoulos-Jeannet F; Jeanrenaud B
Endocrinology; 1992 Jul; 131(1):311-7. PubMed ID: 1612011
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats.
Gil J; Miralpeix M; Carreras J; Bartrons R
J Biol Chem; 1988 Feb; 263(4):1868-71. PubMed ID: 2828354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
